Publications by authors named "Malik Slassi"

Claim this Profile
P
Pharmacological characterisation of psilocybin and 5-MeO-DMT discriminative cues in the rat and their translational value for identifying novel psychedelics.
Guy A Higgins, Cam MacMillan, Ines de Lannoy, Carolyn Tyler, Malik Slassi

J Psychopharmacol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a single psilocybin treatment on Fos protein expression in male rat brain.
Douglas Funk, Joseph Araujo, Malik Slassi, James Lanthier, Jason Atkinson

Neuroscience· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the synergistic mechanism between ibrutinib and daunorubicin in acute myeloid leukemia cells.
Lianne E Rotin, Marcela Gronda, Rose Hurren, XiaoMing Wang, Mark D Minden, Malik Slassi

Leuk Lymphoma· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib synergizes with poly(ADP-ribose) glycohydrolase inhibitors to induce cell death in AML cells via a BTK-independent mechanism.
Lianne E Rotin, Marcela Gronda, Neil MacLean, Rose Hurren, XiaoMing Wang, Malik Slassi

Oncotarget· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel proteasome inhibitors to overcome bortezomib resistance.
Amy M Ruschak, Malik Slassi, Lewis E Kay, Aaron D Schimmer

J Natl Cancer Inst· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The anti-epileptic drug lacosamide (Vimpat) has anxiolytic property in rodents.
Guy A Higgins, Nathalie Breysse, Elijus Undzys, Calvin Kuo, Narges Joharchi, Malik Slassi

Eur J Pharmacol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and biological activity of novel dimethyl-[2-[6-substituted-indol-1-yl]-ethyl]-amine as potent, selective, and orally-bioavailable 5-HT(1D) agonists.
Methvin Isaac, Malik Slassi, Tao Xin, Jalaj Arora, Anne O'Brien

Bioorg Med Chem Lett· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis